HIGHLIGHTS
- who: William L. Redmond and collaborators from the National Research Council (CNR), Italy Northwestern University, United States have published the research: Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA, in the Journal: (JOURNAL)
- what: The authors report here that a-TEA-LS significantly enhanced the anti-tumor efficacy of anti-PD-1 and anti-PD-L1 in multiple tumor models including inducing complete tumor regression in some instances. The authors investigated the extent to which a novel therapy, a-TEALS, in conjunction with aPD-1 or aPD-L1 ICB would impact . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.